« Back to news listing

Cagent Vascular Announces FDA 510(k) Clearance for its Serranator Device for the Infrapopliteal Indication and Completion of its PRELUDE-BTK Clinical Trial Enrollment

Read entire article: https://www.businesswire.com/news/home/20200423005054/en/Cagent-Vascular-Announces-FDA-510-Clearance-Serranator

« Back to news listing